Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Debt to Equity (2021 - 2024)

Historic Debt to Equity for Biofrontera (BFRI) over the last 4 years, with Q2 2024 value amounting to $0.03.

  • Biofrontera's Debt to Equity changed N/A to $0.03 in Q2 2024 from the same period last year, while for Jun 2024 it was $0.03, marking a year-over-year change of. This contributed to the annual value of $0.81 for FY2023, which is 18016.62% up from last year.
  • According to the latest figures from Q2 2024, Biofrontera's Debt to Equity is $0.03.
  • Biofrontera's 5-year Debt to Equity high stood at $6.95 for Q3 2023, and its period low was -$0.43 during Q1 2024.
  • Over the past 4 years, Biofrontera's median Debt to Equity value was $0.29 (recorded in 2021), while the average stood at $1.06.
  • In the last 5 years, Biofrontera's Debt to Equity soared by 474169.56% in 2023 and then tumbled by 20357.96% in 2024.
  • Quarter analysis of 4 years shows Biofrontera's Debt to Equity stood at $0.29 in 2021, then increased by 1.67% to $0.29 in 2022, then skyrocketed by 180.17% to $0.81 in 2023, then plummeted by 96.67% to $0.03 in 2024.
  • Its Debt to Equity stands at $0.03 for Q2 2024, versus -$0.43 for Q1 2024 and $0.81 for Q4 2023.